hubXchange

🚀 Join us at the Antibody Therapeutics Xchange - Maryland 2024! 🔬💡 We're excited to highlight Birthe Jessen-Park, Technical Sales Specialist Custom Antibodies at Bio-Rad Laboratories🌟, an industry leader in antibody discovery, who will be presenting at two exciting sessions during this year's event: 📅 Time: 11:20 AM - 12:20 PM ✨ Roundtable Discussion: "The Perfect Workflow for Generating Antibody Drug Candidates" 🧬 Key topics covered include: 🤔 How many hits (binders) should be further analyzed? 🎯 What are the most relevant selection criteria? 🧠 Solving challenges like affinity, developability, and epitope selection. 📅 Time: 3:35 PM - 4:05 PM 🔍 Poster Presentation: "Rapid Generation of Bispecific Antibodies for High Throughput Screening with SpyLock Technology" 🧫 Birthe will introduce SpyLock Technology 🛠️, an innovative approach for creating bispecific antibodies. This technology, compatible with Bio-Rad’s Pioneer™ Antibody Discovery Platform, offers a faster, more efficient path to discovering bispecifics 🔝. With a rich background at Bio-Rad Laboratories, Alloy Therapeutics, and Medimmune, and a PhD from the University of Freiburg 🎓, Birthe brings unparalleled expertise to these sessions. 📍 Location: College Park Marriott, Maryland 🏨 📅 Date: October 28, 2024 Secure your spot and get your complimentary pass! https://lnkd.in/eqyZAeXX 💬 Don't miss this chance to connect with Birthe and other top industry experts! Let's shape the future of antibody therapeutics together! 💼✨ 💊 Only available for Senior Scientists and above, from Bio and Pharma companies with a drug pipeline. #AntibodyTherapeutics #Biopharma #Biotechnology #PharmaInnovation #AntibodyDiscovery #DrugDevelopment #LeadOptimization #BioRad #TherapeuticsXchange #ADC #MultispecificAntibodies #BiopharmaLeaders #ProteinEngineering #BiotechEvents #PharmaIndustry #LifeSciences #TherapeuticInnovation #BiotechNetworking #ScientificResearch #AntibodyEngineering #PharmaCollaboration #NextGenTherapeutics #BioPharmaExperts #PharmaRND #hubXchange #Xchanges #Roundtable #FreePass #RegisterNow #ComplimentaryPass

🔬 Unlock the Future of AI in Pharma! 🤖 Join us for the Opening Keynote Presentation at the AI in Drug Discovery Xchange - Maryland 2024, where we'll dive into "The Future of AI in Pharma: Accelerating Research Workflows with GenAI." 🔗 Register free today: https://lnkd.in/et4pD_Jn Industry expert Brian Gilman, EVP, Corporate Market, Digital Science will explore the transformative impact of Generative AI (GenAI) on research workflows and literature reviews in the pharmaceutical industry. Discover how GenAI 🤖 and multimodal capabilities are revolutionizing 🔄 data synthesis and screening, and learn how these innovations are accelerating workflows at every stage of research. 🔬✨ Key insights will include: 1. The latest GenAI-driven tools 🛠️ and their integration into pharma research workflows 2. The evolving role of researchers 🧑🔬 as automation reshapes the landscape 3. Ethical considerations ⚖️ in balancing human expertise with AI-driven innovation With AI advancing at lightning speed ⚡, this is a session you don’t want to miss! Get ready to see how AI is augmenting human expertise, driving innovation, and advancing pharma research. 💡 💊 Only available for Senior Scientists and above, from Bio and Pharma companies with a drug pipeline. #AIinPharma #GenerativeAI 🤖 #DrugDiscovery #PharmaInnovation #AIinResearch #GenAI #AI2024 #AIInDrugDiscoveryXchange #PharmaTransformation #ReadCube #ScienceInnovation #AIinHealthcare #AIRevolution #PharmaResearch #GenAIinPharma #AIandScience #FutureOfDrugDiscovery #AIforGood #DataDrivenPharma #PharmaTech #MachineLearningInPharma #AIandEthics #DigitalTransformation #PharmaAutomation #AIWorkflow #hubXchange #Xchanges #Roundtable #FreePass #RegisterNow #ComplimentaryPass

Milestone Celebration! 📈 We’re excited to share that the hubXchange community has officially grown to over 2,000 followers! 🙌 Thank you to everyone who has been a part of our journey. Your engagement and support are what drive us to keep delivering meaningful insights, fostering connections, and fuelling innovation in the life sciences industry. 🌐🔬 At hubXchange, we’re committed to fostering insightful roundtable discussions, exchanging knowledge, and driving meaningful connections within our vibrant network. Want to take part in the next event series? Register now for your COMPLIMENTARY pass! MARYLAND - OCT 2024 (limited passes remain⚠️🚨) 🟡 Antibody Therapeutics Xchange | 28 Oct | https://lnkd.in/ejyQHe-m 🟣 Immunotherapies Xchange | 29 Oct | https://lnkd.in/eE-23YYV 🟠 Oligonucleotide Xchange | 30 Oct | https://lnkd.in/ekmAxemE 🔵 AI in Drug Discovery Xchange | 31 Oct | https://lnkd.in/esnz8pBi BRUSSELS, EU - NOV 2024 🟡 Antibody Therapeutics Xchange | 18 Nov | https://lnkd.in/eGjBd7Xb 🟣 Immunotherapies Xchange | 19 Nov | https://lnkd.in/ePWP9TP7 🟠 Nucleic Acid Xchange | 20 Nov | https://lnkd.in/e3DaiCU7 🔵 AI in Drug Discovery Xchange | 21 Nov | https://lnkd.in/e5xWU7ZH Only available for Senior Scientists and above, from Bio and Pharma companies with a drug pipeline. 💊 See you there! 👋🏾👋🏾👋🏾 #Milestone #ThankYou #LifeSciences #Innovation #hubXchangeCommunity #Collaboration #Growth #RoundtableDiscussions #PharmaIndustry #Biotech #DrugDiscovery #AntibodyTherapeutics #Immunotherapy #NucleicAcidTherapeutics #AIinDrugDiscovery #EventSeries #LifeSciencesNetworking #Roundtable #FreePass #ComplimentaryPass #RegisterNow

🔬 Unlock the Potential of Single Domain Antibodies in Multifunctional Biologics! 🔬 Join us on 18 Nov 2024 from 17:05 - 18:05 at the Antibody Therapeutics Xchange - Brussels 2024 for an insightful roundtable on Opportunities and Challenges of Using Single Domain Antibodies in Novel Multifunctional Biologics. REGISTER FOR FREE: https://lnkd.in/emrZwxYd Led by Tom Van Bogaert, Distinguished Scientist & Innovation Area Head at Sanofi this discussion will dive deep into key topics like: 🔹 The versatility of single domain antibodies and their clinical potential—what are the main challenges? 🔹 Drivers for choosing single domain vs classical antibody formats in multifunctional biologics. 🔹 Areas where single domain antibodies excel and where they fall short compared to conventional antibodies. 🔹 Exploring alternative delivery modes using single domain antibodies beyond classical purified biologics. With Tom's extensive experience leading NANOBODY® programs at Sanofi and Ablynx, this session is a must for anyone interested in cutting-edge antibody research. Only available for Senior Scientists and above, from Bio and Pharma companies, with a drug pipeline. 💊 #AntibodyTherapeutics #SingleDomainAntibodies #Biologics #Sanofi #Pharma #Innovation #AntibodyDevelopment #Xchange #Biotech #LifeSciences #Brussels2024 #MultifunctionalBiologics #NANOBODY #Therapeutics #DrugDevelopment #FormatsAndScaffolds #Immunotherapy #Biopharma #ClinicalResearch #Pharmacology #ScientificRoundtable #hubXchange #Xchanges #Roundtable #FreePass #RegisterNow #ComplimentaryPass

🔬 Join the Science Leaders at Immunotherapies Xchange - Maryland 2024! 🧬 Mark your calendars for October 29th, 2024, from 11:25-12:25 and attend the must attend roundtable discussion on "Project Optimus – The Impact on Protocol Design and Requirements" facilitated by Meredith M., Executive Director, Consulting at Catalyst Clinical Research🧑 🔬 COMPLIMENTARY PASS HERE: https://lnkd.in/eRRRNGiY 💡 Why Attend? This Facilitator will cover: 🟣 FDA’s evolving protocol design requirements for clinical trials 📝 🟣 How these requirements apply to cutting-edge Cell & Gene Therapies (C&GT) 🧫 🟣 The global impact on drug development and regulatory strategies 🌍 🟣 Best practices for managing diverse patient cohorts 👥 With over 30 years of experience in global drug development, including preclinical, regulatory, and clinical stages, Meredith has successfully guided companies through IND and CDx submissions and tackled complex regulatory challenges. 🧪 Her expertise spans from central labs to AI-powered translational research, making her insights invaluable to professionals in the field. 📊 💊Only available for Senior Scientists and above, from Bio and Pharma companies, with a drug pipeline. #ClinicalDevelopment #ProjectOptimus #FDA #CGT #GlobalImpact #Biopharma #DrugDevelopment #ClinicalTrials #ImmunotherapiesXchange #ScienceLeadership #hubXchange #Xchanges #Roundtable #FreePass #RegisterNow #ComplimentaryPass

Happy to share that I will be driving an interesting discussion panel with leading industry experts of the field!

Looking forward to connecting with other experts in biologics development in the Maryland area.

Are you looking to expand your business network and showcase your solutions to top-tier industry leaders? 📈 At hubXchange we create exclusive, invitation-only Xchanges where C-level executives from some of the world’s most innovative life science organizations come together to share knowledge and explore meaningful partnerships. If your company is seeking to position itself as a leader in the life science sector, partnering with hubXchange is your gateway to: ✅ Tailored Engagements: Gain face-to-face access to key decision-makers through curated, small group discussions. ✅ Brand Exposure: Strengthen your company's position as an industry thought leader and build lasting relationships with high-level stakeholders. ✅ Unmatched ROI: Connect with clients ready to take action, optimizing both your time and resources. Our partners have found unparalleled value in these opportunities, leading to meaningful collaborations, investments, and growth. Take your business to the next level with hubXchange. 📅 Ready to partner? Visit our website to learn more about how hubXchange can help you thrive in today’s competitive life sciences market: https://lnkd.in/e2XdDXNs Partnership opportunities for Europe 2024 & San Diego 2025 events now open! ✅ Don't miss your chance to participate in our upcoming events: MARYLAND 2024 🟡 Antibody Therapeutics Xchange Brussels | 18 Nov 2024 🟣 Immunotherapies Xchange Brussels | 19 Nov 2024 🟠 Nucleic Acid Therapeutics Xchange Brussels | 20 Nov 2024 🔵 AI in Drug Discovery Xchange Brussels | 21 Nov 2024 SAN DIEGO 2025 🟡 Antibody Therapeutics Xchange San Diego | 17 Feb 2025 🟣 Immunotherapies Xchange San Diego| 18 Feb 2025 🔵 AI in Drug Discovery Xchange San Diego | 20 Feb 2025 🟢 Advanced Therapies Xchange San Diego | 21 Feb 2025 Clarence Maguire-Swartz, Jethro Curtis, Robert Lishmund #LifeSciences #BusinessPartnerships #Innovation #Networking #hubXchange #IndustryLeaders #Partnerships #Biotech #Pharma #Roundtables #NewPartnerships #SponsorCallout #NewWayToNetwork

🚀 Unlock the Future of Drug Discovery with AI - Featuring Dominik Vahrenhorst! We’re thrilled to have Dominik Vahrenhorst, Associate Director Bioinformatics at CureVac CureVac Netherlands, leading an exciting roundtable discussion on AI-driven drug development at the AI in Drug Discovery Xchange - Brussels 2024! 🤖💡 🔗 Register today and get your Complimentary Pass! https://lnkd.in/ewu8qBsA Session Details: 🎯 Topic: Developing drug substances using AI-driven computational solutions with increased efficacy and reduced side effects 🗓️ When: 21 November 2024, 15:35 - 16:45 📍 Where: DoubleTree by Hilton Brussels City 🔬 Track: Lead Generation & Optimization What You’ll Learn: 💡 AI in action: How AI is revolutionizing drug design and optimization. 🔬 Overcoming challenges: Addressing issues in broader design spaces, especially for mRNA-based therapeutics. 🤝 Human-data integration: Incorporating human-derived responses to enhance AI models for better drug efficacy. 📑 Regulatory outlook: Exploring the potential for standardized validation data packages to accelerate AI-based drug development. About Dominik Vahrenhorst: Dominik brings a wealth of knowledge and experience from his time at CureVac and Immatics, where he has been instrumental in building AI capabilities for drug discovery and mRNA therapeutics. His expertise spans clinical trial data analysis and AI-driven solutions across the drug development process. 🧬📊 Don't miss this opportunity to engage with an industry leader driving innovation in AI and drug discovery! 🌟 💊 Only available for Senior Scientists and above, from Bio and Pharma companies, with a drug pipeline. 💊 #AIinDrugDiscovery #AIinPharma #Bioinformatics #DrugDevelopment #mRNA #AIDriven #Innovation #ClinicalTrials #Pharma #Biotech #Therapeutics #AIinHealthcare #DrugDesign #AIResearch #ComputationalBiology #hubXchange #Xchanges #Roundtable #FreePass #RegisterNow #ComplimentaryPass

🚀 Don't Miss Shuji Sato at Antibody Therapeutics Xchange - Maryland 2024! 🚀 We're thrilled to feature Shuji Sato, Senior Director of Client Relations at IPA (ImmunoPrecise Antibodies), as he leads a must-see poster presentation at the Antibody Therapeutics Xchange - Maryland 2024! 🎉✨ 🎯 Session Details: Topic: Strategies to Amplify the Therapeutic Potential of Rabbit-Derived Antibodies 🧬 Track: Lead Identification & Optimization Time: ⏰ 15:35 - 16:05 | 🗓 Monday, October 28, 2024 With a PhD from Tufts University and postdoctoral training at Harvard Medical School, Shuji brings a wealth of knowledge from his work at leading biotech and pharma companies, including Pfizer and Dragonfly Therapeutics. This is an incredible opportunity to engage with thought leaders driving innovation in antibody therapeutics.🌟🧪 📍 Location: Marriott College Park, Maryland 🕗 Event Hours: 08:00 AM - 06:05 PM 👉 REGISTER NOW to engage with top experts and fuel your antibody discovery journey! 🚀💡 https://lnkd.in/dKKADwUU 💊 Only available for Senior Scientists and above, from Bio and Pharma companies with a drug pipeline. #AntibodyTherapeutics #BiotechInnovation #PharmaLeadership #Immunoprecise #Networking #AntibodyDiscovery #ScienceInAction #Biotechnology #PharmaResearch #TherapeuticDevelopment #DrugDiscovery #LeadOptimization #BiotechLeaders #PharmaInnovation #Therapeutics #Immunology #BioPharma #ClinicalResearch #hubXchange #Xchanges #Roundtable #FreePass #RegisterNow #ComplimentaryPass